- PRICING
- LIVE QUOTES
- LEARN
- HELP
EN
3 Market-Beating Stocks to Research Further
Companies that consistently increase their sales, margins, or returns on capital are usually rewarded with the best returns, and those that can do all three for years on end are almost always the legendary stocks that return 100 times your money.
The bottom line is that over the long term, earnings growth goes hand in hand with the biggest winners. Taking that into account, here are three market-beating stocks that deserve a spot on your list.
AAON (AAON)
Five-Year Return: +93.5%
Backed by two million square feet of lab testing space, AAON (NASDAQ:AAON) makes heating, ventilation, and air conditioning equipment for different types of buildings.
Why Does AAON Stand Out?
- Average backlog growth of 93.5% over the past two years shows it has a steady sales pipeline that will drive future orders
- Market share will likely rise over the next 12 months as its expected revenue growth of 26.5% is robust
- Industry-leading 17.4% return on capital demonstrates management’s skill in finding high-return investments
At $87.81 per share, AAON trades at 32.1x forward P/E. Is now the right time to buy? See for yourself in our in-depth research report, it’s free.
Interface (TILE)
Five-Year Return: +187%
Pioneering carbon-neutral flooring since its founding in 1973, Interface (NASDAQ:TILE) is a global manufacturer of modular carpet tiles, luxury vinyl tile (LVT), and rubber flooring that specializes in carbon-neutral and sustainable flooring solutions.
Why Are We Fans of TILE?
- Incremental sales significantly boosted profitability as its annual earnings per share growth of 34.1% over the last two years outstripped its revenue performance
- Free cash flow margin expanded by 7.5 percentage points over the last five years, providing additional flexibility for investments and share buybacks/dividends
- Returns on capital are climbing as management makes more lucrative bets
Interface is trading at $37.96 per share, or 1.6x trailing 12-month price-to-sales. Is now the time to initiate a position? Find out in our full research report, it’s free.
Hims & Hers Health (HIMS)
Five-Year Return: +308%
Originally launched with a focus on stigmatized conditions like hair loss and sexual health, Hims & Hers Health (NYSE:HIMS) operates a consumer-focused telehealth platform that connects patients with healthcare providers for prescriptions and wellness products.
Why Could HIMS Be a Winner?
- Business is winning new contracts that can potentially increase in value as its customer base averaged 25.1% growth over the past two years
- Free cash flow margin jumped by 15.9 percentage points over the last five years, giving the company more resources to pursue growth initiatives, repurchase shares, or pay dividends
- Historical investments are beginning to pay off as its returns on capital are growing
Hims & Hers Health’s stock price of $28.19 implies a valuation ratio of 19.3x forward P/E. Is now a good time to buy? See for yourself in our comprehensive research report, it’s free.
High-Quality Stocks for All Market Conditions
ONE MORE THING: Top 5 Growth Stocks. The biggest stock winners almost always had one thing in common before they ran. Revenue growing like crazy. Meta. CrowdStrike. Broadcom. Our AI flagged all three. They returned 315%, 314%, and 455%, respectively.
Find out which 5 stocks it’s flagging this month — FREE. Get Our Top 5 Growth Stocks for Free HERE.
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+214% between June 2020 and June 2025). Find your next big winner with StockStory today.